Keyphrases
Confidence Interval
69%
T Cells
46%
Tumor
44%
Heart Failure
44%
COVID-19
40%
Macrophages
37%
United States
35%
Natural Killer Cells
31%
Older Adults
29%
Gene Expression
29%
Clinical Trials
28%
Inflammation
28%
Risk Factors
28%
Diabetes
27%
Clinical Outcomes
27%
Overall Survival
26%
Odds Ratio
25%
Hazard Ratio
24%
Obesity
24%
High Risk
23%
Chemotherapy
23%
Meta-analysis
22%
Lung
22%
Insulin
21%
Cardiovascular Disease
21%
Placebo
21%
Virus
21%
Kidney
20%
Mouse Model
20%
Breast Cancer
20%
Liver
20%
Myocardial Infarction
20%
Acute Myeloid Leukemia
19%
Lung Transplantation
19%
Randomized Controlled Trial
19%
Type 2 Diabetes Mellitus (T2DM)
19%
Dendritic Cells
18%
Phase II Study
18%
Adverse Events
18%
Left Ventricular Function
18%
Monoclonal Antibody
18%
Interferon-α (IFN-α)
18%
Acute Myocardial Infarction
18%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
18%
Immune Response
17%
Phase II Trial
17%
Interleukin-1β
17%
Transcription Factor
17%
In Cancer
17%
Neutrophils
17%
Multiple Myeloma
17%
Hospitalization
17%
Type 1 Diabetes Mellitus (T1DM)
16%
Apoptosis
16%
Osteoclast
16%
AIDS/HIV
16%
Phosphorylation
16%
Hypertension
16%
Transplantation
15%
Granulocyte Colony-stimulating Factor (G-CSF)
15%
Coronary Artery Disease
15%
Hematopoietic Stem Cells
15%
Tumor Necrosis Factor-α
15%
Overexpression
15%
Chronic Kidney Disease
15%
Antiretroviral Therapy
15%
Quality of Life
15%
B Cells
14%
Progression-free Survival
14%
CD8+ T Cells
14%
Integrin
14%
Non-small Cell Lung Cancer (NSCLC)
14%
Asthma
13%
Lipids
13%
Gene-deficient Mice
13%
Insulin Resistance
13%
Bone Marrow
13%
Ca2+
13%
Human Immunodeficiency Virus Type 1 (HIV-1)
13%
Percutaneous Coronary Intervention
12%
Metabolism
12%
Amino Acids
12%
Transgenic Mice
12%
Systematic Meta-analysis
12%
Weight Loss
12%
People Living with HIV (PLHIV)
12%
Inflammatory Bowel Disease
12%
Patients with Heart Failure
12%
Randomized Clinical Trial
12%
Intensive Care Unit
12%
Relapsed or Refractory
12%
Randomized Trial
11%
Comorbidity
11%
Fatty Acids
11%
Complementary DNA (cDNA)
11%
Lymphocytes
11%
Knock-in Mouse Model
11%
Cholesterol
11%
Graft-versus-host Disease (GvHD)
11%
Hypoglycemia
11%
Medicine and Dentistry
Diseases
100%
Neoplasm
59%
Congestive Heart Failure
51%
Infection
46%
Malignant Neoplasm
44%
Human Immunodeficiency Virus
39%
COVID-19
32%
Breast Cancer
31%
Cardiovascular System
29%
Clinical Trial
28%
Diabetes
28%
Lung
27%
Overall Survival
26%
Diagnosis
26%
Odds Ratio
25%
Prevalence
24%
Cardiovascular Disease
23%
Transplantation
23%
Cancer
21%
Adverse Event
21%
In Vitro
21%
Health Care Cost
21%
Biological Marker
20%
Receptor
20%
Hazard Ratio
19%
Systematic Review
19%
T Cell
19%
Surgery
18%
Clinician
18%
Quality of Life
18%
Hematopoietic Cell
18%
Macrophage
17%
Oncology
17%
Meta-Analysis
16%
Lung Transplantation
16%
Placebo
16%
Multiple Myeloma
16%
Randomized Controlled Trial
15%
Myocardial Infarction
15%
Medicare
15%
Metastatic Carcinoma
15%
Progression Free Survival
14%
Gene Expression
14%
Messenger RNA
13%
Immunity
13%
Arm
13%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Recurrent Disease
13%
Acute Myeloid Leukemia
13%
Cohort Analysis
12%
Chronic Kidney Disease
12%
Maturity Onset Diabetes of the Young
12%
Diabetes Mellitus
12%
Apoplexy
12%
Radiation Therapy
12%
Coronary Artery Disease
12%
Combination Therapy
12%
Non Small Cell Lung Cancer
12%
Intensive Care Unit
12%
Comorbidity
12%
Pediatrics
11%
Percutaneous Coronary Intervention
11%
Acute Heart Infarction
11%
Immunotherapy
11%
Biopsy Technique
11%
Cytokine
11%
Cohort Effect
11%
Health Care
11%
Stem Cell
11%
Tumor Necrosis Factor
11%
Body Mass Index
10%
Outpatient
10%
Epithelial Cell
10%
Lung Cancer
10%
Magnetic Resonance Imaging
10%
Medicine
10%
Isotopes of Calcium
10%
Disease
10%
Emergency Department
10%
Programmed Cell Death
10%
Asthma
9%
Homeostasis
9%
B Cell
9%
Echocardiography
9%
Calcium Ion
9%
Allograft
9%
Nephropathy
9%
Antiretroviral Therapy
9%
Targeted Therapy
9%
Primary Health Care
9%
Melanoma
9%
Pathogen
9%
Colorectal Carcinoma
9%
Atrial Fibrillation
9%
Sepsis
9%
Acute Kidney Injury
8%
Logistic Regression Analysis
8%
Lymphocyte
8%
Bleeding
8%
Hemodynamic
8%